Growth hormone receptor antagonist therapy in acromegalic patients resistant to somatostatin analogs

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 8, 2000, Pages 2958-2961

  Herman Bonert, Vivien S ^a   Zib, Kenneth ^b   Scarlett, John A ^b   Melmed, Shlomo ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Sensus Drug Development Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; BROMOCRIPTINE; DOPAMINE RECEPTOR STIMULATING AGENT; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; GROWTH HORMONE RECEPTOR ANTAGONIST; OCTREOTIDE; PEGVISOMANT; PERGOLIDE MESILATE; RECEPTOR BLOCKING AGENT; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE; UNCLASSIFIED DRUG;

ACROMEGALY; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG RECEPTOR BINDING; FEMALE; GROWTH HORMONE RELEASE; HORMONE BLOOD LEVEL; HORMONE INHIBITION; HUMAN; HYPOPHYSIS ADENOMA; MALE; PRIORITY JOURNAL; TRANSSPHENOIDAL HYPOPHYSECTOMY;

ACROMEGALY; ADULT; BROMOCRIPTINE; DRUG RESISTANCE; FEMALE; HORMONE ANTAGONISTS; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; OCTREOTIDE; RECEPTORS, SOMATOTROPIN; TREATMENT FAILURE;

EID: 0034456782     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.8.2958     Document Type: Article

References (30)

1. Acromegaly
2. Stimulation of adenosine 3′,5′- monophosphate production by growth hormone-releasing factors and its inhibition by somatostatin in anterior pituitary cells in vitro
3. The mechanisms by which growth hormone brings about growth
4. Determinants of clinical outcome and survival in acromegaly
5. An audit of outcome of treatment in acromegaly
6. Tight contol of growth hormone: An attainable outcome for acromegaly treatment
7. Treatment of acromegaly with dopamine agonists
8. Cabergoline in the treatment of acromegaly: A study in 64 patients
9. SMS 201-995. A very potent and selective octapeptide analog of somatostatin with prolonged action
10. Treatment of resistant acromegaly with a long-acting somatostain analogue (SMS 201-995)
11. Three year follow-up of acromegalic patients treated with intramuscular slow-release lanreotide
12. Safety and efficacy of long term octeotide therapy of acromegaly: Results of a multicenter trial in 103 patients - A clinical research center study
13. Sandostatin LAR in acromegalic patients: Long term treatment
14. Treatment of acromegaly with the growth hormone receptor antagonist pegvisomant
15. Somatostain. Part I
16. Molecular biology of somatostatin receptors
17. The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors
18. The growth hormone responses to octreotide in acromegaly correlate with adenoma somatostatin receptor status
19. Somatostatin receptors, adenylate cyclase activity and GH response to octreotide in GH-secreting adenomas
20. Heterogeneous expression of two somatostatin receptor subtypes in pituitary tumors
21. Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5)
22. Somatostatin receptor subtype specificity in human fetal pituitary cultures: Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone and prolactin regulation
23. Human growth hormone and the extracellular domain of its receptor: Crystal structure of the complex
24. Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule
25. Preparation and characterization of poly(ethylene glycol)ylated human growth hormone antagonist
26. PEG-modified proteins
27. Rational design of potent antagonists to the human growth hormone receptor
28. Expression of a mutated bovine growth hormone gene suppresses growth of transgenic mice
29. Functional antagonism between endogenous mouse growth hormone (GH) and a GH analog results in dwarf transgenic mice
30. In vitro and in vivo studies of antagonistic effects of human growth hormone analogs